Rosybel Drury | Senior Director Global Medical & Scientific Affair
MSD

Rosybel Drury, Senior Director Global Medical & Scientific Affair, MSD

Rosybel Drury is a seasoned professional with over 20 years of experience in the pharmaceutical industry, currently serving as the Senior Director of Global Medical & Scientific Affairs at MSD. With a strong background in research, development, and strategic partnering, Rosybel has a proven track record of driving innovation and success in the global vaccine industry.

Throughout her career, Rosybel has played a key role in the development and commercialization of numerous vaccines, contributing to the advancement of public health on a global scale. Her expertise lies in forging strategic partnerships with key stakeholders, leading cross-functional teams, and navigating complex regulatory landscapes to bring life-saving vaccines to market.

Rosybel is known for her strong leadership skills, strategic vision, and ability to drive results in fast-paced and dynamic environments. She is passionate about leveraging her scientific and medical knowledge to address unmet medical needs and improve patient outcomes worldwide.

As a speaker at the World Vaccine Congress Europe 2025, Rosybel will share her insights and expertise on research, development, and strategic partnering in the global vaccine industry. Attendees can expect to gain valuable knowledge and perspectives from her presentation, informed by her extensive experience and dedication to advancing vaccine innovation and accessibility.

Appearances:



Day 2 - Wednesday 15th October @ 15:45

Comparative analysis of evidence generation approaches for vaccines in outbreak settings

  • Significant progress in research on arboviruses and flaviviruses; dengue, tick-borne encephalitis, yellow fever 
  • Evolving regulatory approaches for trials, adapting to new technologies and global health challenges 
  • Chikungunya case study; navigating multi-country licensure challenges and innovative regulatory approaches 
  • Evidence generation under pressure; balancing urgent public health needs with trial rigour 
  • Post-licensure trials in non-licensed markets; regulatory, ethical and operational complexities 
  • How global regulators are evolving approaches to support both emergency responses and robust scientific evaluation during outbreaks  
last published: 06/Aug/25 15:15 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.